Results 141 to 150 of about 64,832 (295)
Phase II study of pregabalin for the prevention of chemotherapy induced nausea and vomiting
To evaluate the role of pregabalin in the protection of chemotherapy-induced nausea and vomiting, we performed a phase II randomized, double-blind, placebo-controlled trial to investigate whether pregabalin could improve the complete control of nausea ...
Carla Santos Rossi Paniquar +3 more
doaj +1 more source
This systematic review explores how individuals with cancer, chronic obstructive pulmonary disease (COPD), diabetes and coronary heart disease adapt to the complex challenges posed by chronic illness. The review was designed to identify, categorise and compare coping strategies across these conditions, while also examining how personal experiences ...
Andrew Kweku Conduah +2 more
wiley +1 more source
Urothelial carcinoma: Perioperative considerations from top to bottom
Abstract Urothelial carcinoma is an aggressive entity that is associated with significant morbidity, but there have been major advances in both our understanding of and treatment options for patients with this disease. In this review, the authors focus on novel therapeutic and diagnostic approaches in the perioperative setting, with an emphasis on ...
Wesley Yip +8 more
wiley +1 more source
Role of dexamethasone dosage in combination with 5-HT3 antagonists for prophylaxis of acute chemotherapy-induced nausea and vomiting [PDF]
Karsten Münstedt +5 more
openalex +1 more source
A Smartphone-Based Decision Support Tool for Predicting Patients at Risk of Chemotherapy-Induced Nausea and Vomiting: Retrospective Study on App Development Using Decision Tree Induction [PDF]
Abu Saleh Mohammad Mosa +4 more
openalex +1 more source
PARP Inhibitors in the Treatment of Prostate Cancer: An Analysis of the Clinical Trial Landscape
ABSTRACT Background Prostate cancer remains one of the most prevalent cancers among men worldwide, particularly in the context of metastatic castration‐resistant prostate cancer (mCRPC), which poses significant treatment challenges. PARP inhibitors offer a promising therapeutic option for patients with homologous recombination repair (HRR) deficiencies.
Yanru Chen +7 more
wiley +1 more source
Neurokinin-1 Receptor Antagonists for Chemotherapy-Induced Nausea and Vomiting: A Systematic Review [PDF]
Lucas Vieira dos Santos +4 more
openalex +1 more source
Megan Crichton +10 more
semanticscholar +1 more source

